With the world waiting, Roche socks $459M into COVID-19 antibody test production
Roche received the FDA's emergency use nod for its COVID-19 antibody test late last week. (Roche)
Roche scored a major win with the FDA's backing for its COVID-19 antibody tests last week in a field marked by products of questionable quality. Now, to cover its booming production goals, Roche plans to infuse nearly half-a-billion dollars into its German manufacturing facility.
Roche will plow $459 million into its manufacturing facility in Penzberg, Germany, to boost production of the antibody test that won an emergency use authorization from the FDA last week, Reuters reported.
At a German Ethics Council meeting Monday, officials said the government had signed a deal with Roche to secure 3 million diagnostic tests in May and an additional 5 million each following month. Eventually, Roche will aim to produce nearly 100 million tests per month by the end of 2020, according to Reuters.
How to Streamline Your Clinical Research Organization's Processes End to End
Learn how implementing one platform leads to data consistency and ultimately facilitate faster clinical trials while reducing overall trial costs, leave behind spreadsheets and home-grown tools for a predictable trial and the ability to forecast unit delivery resulting in the optics you need to ensure a successful trial, and hear experts share industry trends of what is affecting the Clinical Research Organization industry today.
Roche is reportedly also working on a four-year plan to develop a brand-new research and diagnostic center.
After the FDA approval Friday, Roche said it is prepared to produce "high double-digit millions" of the tests in May with the intent to continue ramping up production.